Clinical Report: Zeiss MICOR 700 Ultrasonic-Free Cataract Surgery Device

Overview

The Zeiss MICOR 700 introduces a novel non-ultrasonic lens removal technology for cataract surgery, representing a paradigm shift from traditional phacoemulsification. This handheld device uses a mechanical three-piston pump and cavitation-free oscillation to reduce thermal and fluidic stress on ocular tissues, potentially improving patient outcomes and surgical efficiency.

Background

For over six decades, ultrasound phacoemulsification has been the standard technique for cataract extraction. Despite refinements, phaco relies on high-frequency ultrasonic energy that can generate heat and cavitation, posing risks to ocular tissues. The MICOR 700, recently launched for broad US distribution, offers a mechanical alternative that eliminates ultrasound use, aiming to minimize thermal damage and reduce fluid usage during surgery. This innovation may benefit patients with compromised corneas or endothelial dystrophies and improve postoperative recovery.

Data Highlights

Key Findings

• The MICOR 700 uses a handheld mechanical system with a three-piston displacement pump, generating vacuum and oscillation near the eye, reducing post-occlusion surge risk.
• It operates at 40 Hz with cavitation-free oscillation, avoiding heat generation typical of ultrasonic phacoemulsification.
• Fluidics control close to the eye allows significantly less fluid infusion (18-30 mL) compared to phaco (50-200 mL), reducing endothelial stress and corneal edema.
• The device features a blunt tip with rounded edges to minimize tissue damage during lens extraction.
• Clinical use shows faster setup time (~30 seconds) and comparable nucleus removal times (20-30 seconds) to traditional phaco.
• Surgeons report clearer corneas and improved postoperative day one vision in patients treated with MICOR 700, especially in cases with compromised corneas or softer cataracts.

Clinical Implications

The MICOR 700 offers a safer alternative to ultrasound phacoemulsification by minimizing thermal and fluidic trauma, which may enhance corneal clarity and accelerate visual recovery. Its compact handheld design and rapid setup can improve operating room efficiency and reduce costs. Surgeons may consider MICOR 700 particularly for patients with endothelial compromise, softer cataracts, or premium intraocular lens implantation.

Conclusion

The Zeiss MICOR 700 represents a landmark advancement in cataract surgery technology by eliminating ultrasound energy and reducing fluid use, potentially improving patient outcomes and surgical workflow. It complements rather than replaces phacoemulsification, expanding options for tailored cataract care.

References

1. Yoo SH, Desai NR, Zeiss 2024 -- Spotlight on Technology & Technique: Zeiss MICOR 700